A multi-modal MRI study of the central response to inflammation in rheumatoid arthritis
Andrew Schrepf, Chelsea M Kaplan, Eric Ichesco, Tony Larkin, Steven E Harte, Richard E Harris, Alison D Murray, Gordon D Waiter, Daniel J Clauw, Neil Basu, Andrew Schrepf, Chelsea M Kaplan, Eric Ichesco, Tony Larkin, Steven E Harte, Richard E Harris, Alison D Murray, Gordon D Waiter, Daniel J Clauw, Neil Basu
Abstract
It is unknown how chronic inflammation impacts the brain. Here, we examined whether higher levels of peripheral inflammation were associated with brain connectivity and structure in 54 rheumatoid arthritis patients using functional and structural MRI. We show that higher levels of inflammation are associated with more positive connections between the inferior parietal lobule (IPL), medial prefrontal cortex, and multiple brain networks, as well as reduced IPL grey matter, and that these patterns of connectivity predicted fatigue, pain and cognitive dysfunction. At a second scan 6 months later, some of the same patterns of connectivity were again associated with higher peripheral inflammation. A graph theoretical analysis of whole-brain functional connectivity revealed a pattern of connections spanning 49 regions, including the IPL and medial frontal cortex, that are associated with peripheral inflammation. These regions may play a critical role in transducing peripheral inflammatory signals to the central changes seen in rheumatoid arthritis.
Conflict of interest statement
Pfizer provided supplementary funding to N.B. for data acquisition. D.J.C. has consulted or served as an expert witness for Forest Laboratories, Pfizer, Inc, Cerephex Corp, Eli Lilly and Company, Merck & Co, Nuvo Research Inc, Tonix Pharmaceuticals, Johnson & Johnson, Pierre Fabre, Cypress Biosciences, Wyeth Pharmaceuticals, UCB, AstraZeneca, Jazz Pharmaceuticals, Abbott Laboratories, and Iroko Pharmaceuticals. R.E.H. has consulted for Pfizer, Inc. S.E.H. has received research funding from Aptinyx, Cerephex, Eli Lily, Forest Laboratories, and Merck and served as a consultant for Pfizer, Analgesic Solutions, Aptinyx, and deCode Genetics. A.S., C.M.K., S.E.H., R.E.H., T.L., E.I., and D.J.C. have all received funding from the National Institutes of Health. The remaining authors declare no competing interests.
Figures
References
- Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 2008;9:46–56. doi: 10.1038/nrn2297.
- Andresdottir MB, Sigfusson N, Sigvaldason H, Gudnason V. Erythrocyte sedimentation rate, an independent predictor of coronary heart disease in men and women: the Reykjavik Study. Am. J. Epidemiol. 2003;158:844–851. doi: 10.1093/aje/kwg222.
- Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001;286:327–334. doi: 10.1001/jama.286.3.327.
- Siemes C, et al. C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study. J. Clin. Oncol. 2006;24:5216–5222. doi: 10.1200/JCO.2006.07.1381.
- Chapman DP, Perry GS, Strine TW. The vital link between chronic disease and depressive disorders. Prev. Chronic Dis. 2005;2:A14.
- McInnes IB, Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat. Rev. Immunol. 2007;7:429–442. doi: 10.1038/nri2094.
- Eisenberger NI, Inagaki TK, Mashal NM, Irwin MR. Inflammation and social experience: an inflammatory challenge induces feelings of social disconnection in addition to depressed mood. Brain Behav. Immun. 2010;24:558–563. doi: 10.1016/j.bbi.2009.12.009.
- Harrison NA, et al. Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity. Biol. Psychiatry. 2009;66:407–414. doi: 10.1016/j.biopsych.2009.03.015.
- Capuron L, et al. Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology. 2002;26:643–652. doi: 10.1016/S0893-133X(01)00407-9.
- Prevoo ML, et al. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995;38:44–48. doi: 10.1002/art.1780380107.
- Beckmann CF, DeLuca M, Devlin JT, Smith SM. Investigations into resting-state connectivity using independent component analysis. Philos. Trans. R. Soc. B. 2005;360:1001–1013. doi: 10.1098/rstb.2005.1634.
- Power JD, et al. Functional network organization of the human brain. Neuron. 2011;72:665–678. doi: 10.1016/j.neuron.2011.09.006.
- Zalesky A, Fornito A, Bullmore ET. Network-based statistic: identifying differences in brain networks. Neuroimage. 2010;53:1197–1207. doi: 10.1016/j.neuroimage.2010.06.041.
- Bullmore E, Sporns O. Complex brain networks: graph theoretical analysis of structural and functional systems. Nat. Rev. Neurosci. 2009;10:186–198. doi: 10.1038/nrn2575.
- van den Heuvel MP, Sporns O. Network hubs in the human brain. Trends Cogn. Sci. 2013;17:683–696. doi: 10.1016/j.tics.2013.09.012.
- Wells G, et al. Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate. Ann. Rheum. Dis. 2009;68:954–960. doi: 10.1136/ard.2007.084459.
- McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N. Engl. J. Med. 2011;365:2205–2219. doi: 10.1056/NEJMra1004965.
- Hess A, et al. Blockade of TNF-α rapidly inhibits pain responses in the central nervous system. Proc. Natl. Acad. Sci. USA. 2011;108:3731–3736. doi: 10.1073/pnas.1011774108.
- Nikolaus S, Bode C, Taal E, de Laar MA. Fatigue and factors related to fatigue in rheumatoid arthritis: a systematic review. Arthritis Care Res. 2013;65:1128–1146. doi: 10.1002/acr.21949.
- Harrison NA, Cercignani M, Voon V, Critchley HD. Effects of inflammation on hippocampus and substantia nigra responses to novelty in healthy human participants. Neuropsychopharmacology. 2015;40:831–838. doi: 10.1038/npp.2014.222.
- Benson S, et al. Acute experimental endotoxemia induces visceral hypersensitivity and altered pain evaluation in healthy humans. Pain. 2012;153:794–799. doi: 10.1016/j.pain.2011.12.001.
- Kullmann JS, et al. Experimental human endotoxemia enhances brain activity during social cognition. Soc. Cogn. Affect. Neurosci. 2014;9:786–793. doi: 10.1093/scan/nst049.
- Eisenberger NI, Inagaki TK, Rameson LT, Mashal NM, Irwin MR. An fMRI study of cytokine-induced depressed mood and social pain: the role of sex differences. Neuroimage. 2009;47:881–890. doi: 10.1016/j.neuroimage.2009.04.040.
- Salaffi F, Carotti M, Gasparini S, Intorcia M, Grassi W. The health-related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a comparison with a selected sample of healthy people. Health Qual. Life Outcomes. 2009;7:25. doi: 10.1186/1477-7525-7-25.
- Labrenz F, et al. Alterations in functional connectivity of resting state networks during experimental endotoxemia–an exploratory study in healthy men. Brain Behav. Immun. 2016;54:17–26. doi: 10.1016/j.bbi.2015.11.010.
- Vatansever D, Menon DK, Manktelow AE, Sahakian BJ, Stamatakis EA. Default mode network connectivity during task execution. Neuroimage. 2015;122:96–104. doi: 10.1016/j.neuroimage.2015.07.053.
- Vatansever D, Menon DK, Manktelow AE, Sahakian BJ, Stamatakis EA. Default mode dynamics for global functional integration. J. Neurosci. 2015;35:15254–15262. doi: 10.1523/JNEUROSCI.2135-15.2015.
- Reuter-Lorenz PA, Cappell KA. Neurocognitive aging and the compensation hypothesis. Curr. Dir. Psychol. Sci. 2008;17:177–182. doi: 10.1111/j.1467-8721.2008.00570.x.
- Wallin K, et al. Midlife rheumatoid arthritis increases the risk of cognitive impairment two decades later: a population-based study. J. Alzheimers Dis. 2012;31:669–676. doi: 10.3233/JAD-2012-111736.
- Chou RC, Kane M, Ghimire S, Gautam S, Gui J. Treatment for rheumatoid arthritis and risk of Alzheimer’s disease: a nested case-control analysis. CNS Drugs. 2016;30:1111–1120. doi: 10.1007/s40263-016-0374-z.
- Guo CC, et al. Network-selective vulnerability of the human cerebellum to Alzheimer’s disease and frontotemporal dementia. Brain. 2016;139:1527–1538. doi: 10.1093/brain/aww003.
- Jacobs HIL, et al. The cerebellum in Alzheimer’s disease: evaluating its role in cognitive decline. Brain. 2018;141:37–47. doi: 10.1093/brain/awx194.
- Loggia ML, et al. Evidence for brain glial activation in chronic pain patients. Brain. 2015;138:604–615. doi: 10.1093/brain/awu377.
- Hillmer AT, et al. Microglial depletion and activation: a [(11)C]PBR28 PET study in nonhuman primates. EJNMMI Res. 2017;7:59. doi: 10.1186/s13550-017-0305-0.
- Kreisl WC, et al. In vivo radioligand binding to translocator protein correlates with severity of Alzheimer’s disease. Brain. 2013;136:2228–2238. doi: 10.1093/brain/awt145.
- Aletaha D, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62:2569–2581. doi: 10.1002/art.27584.
- Chalder T, et al. Development of a fatigue scale. J. Psychosom. Res. 1993;37:147–153. doi: 10.1016/0022-3999(93)90081-P.
- Yarkoni T. Big correlations in little studies: inflated fMRI correlations reflect low statistical power-commentary on Vul et al. (2009) Perspect. Psychol. Sci. 2009;4:294–298. doi: 10.1111/j.1745-6924.2009.01127.x.
- Wolfe F, Pincus T. The level of inflammation in rheumatoid arthritis is determined early and remains stable over the longterm course of the illness. J. Rheumatol. 2001;28:1817–1824.
- Wang W, et al. The Th17/Treg imbalance and cytokine environment in peripheral blood of patients with rheumatoid arthritis. Rheumatol. Int. 2012;32:887–893. doi: 10.1007/s00296-010-1710-0.
- Brennan FM, McInnes IB. Evidence that cytokines play a role in rheumatoid arthritis. J. Clin. Investig. 2008;118:3537–3545. doi: 10.1172/JCI36389.
- Sharma R, et al. The relationship of the erythrocyte sedimentation rate to inflammatory cytokines and survival in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors. J. Am. Coll. Cardiol. 2000;36:523–528. doi: 10.1016/S0735-1097(00)00745-2.
- Hardy R, et al. Local and systemic glucocorticoid metabolism in inflammatory arthritis. Ann. Rheum. Dis. 2008;67:1204–1210. doi: 10.1136/ard.2008.090662.
- Pepys MB. C-reactive protein fifty years on. Lancet. 1981;1:653–657. doi: 10.1016/S0140-6736(81)91565-8.
- Wolfe F, et al. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. J. Rheumatol. 2011;38:1113–1122. doi: 10.3899/jrheum.100594.
- Cook DB, O’Connor PJ, Lange G, Steffener J. Functional neuroimaging correlates of mental fatigue induced by cognition among chronic fatigue syndrome patients and controls. Neuroimage. 2007;36:108–122. doi: 10.1016/j.neuroimage.2007.02.033.
- Basu N, et al. Neural correlates of fatigue in granulomatosis with polyangiitis: a functional magnetic resonance imaging study. Rheumatology (Oxf.) 2014;53:2080–2087. doi: 10.1093/rheumatology/keu243.
- Cole MW, Bassett DS, Power JD, Braver TS, Petersen SE. Intrinsic and task-evoked network architectures of the human brain. Neuron. 2014;83:238–251. doi: 10.1016/j.neuron.2014.05.014.
- Calhoun VD, Adali T, Pekar JJ. A method for comparing group fMRI data using independent component analysis: application to visual, motor and visuomotor tasks. Magn. Reson. Imaging. 2004;22:1181–1191. doi: 10.1016/j.mri.2004.09.004.
- Smith SM, et al. Correspondence of the brain’s functional architecture during activation and rest. Proc. Natl. Acad. Sci. USA. 2009;106:13040–13045. doi: 10.1073/pnas.0905267106.
- Whitfield-Gabrieli S, Nieto-Castanon A. Conn: a functional connectivity toolbox for correlated and anticorrelated brain networks. Brain Connect. 2012;2:125–141. doi: 10.1089/brain.2012.0073.
- Birn RM, et al. The effect of scan length on the reliability of resting-state fMRI connectivity estimates. Neuroimage. 2013;83:550–558. doi: 10.1016/j.neuroimage.2013.05.099.
- Poldrack RA. Region of interest analysis for fMRI. Soc. Cogn. Affect. Neurosci. 2007;2:67–70. doi: 10.1093/scan/nsm006.
- Cohen AL, et al. Defining functional areas in individual human brains using resting functional connectivity MRI. Neuroimage. 2008;41:45–57. doi: 10.1016/j.neuroimage.2008.01.066.
- Cole MW, et al. Multi-task connectivity reveals flexible hubs for adaptive task control. Nat. Neurosci. 2013;16:1348–1355. doi: 10.1038/nn.3470.
- Dosenbach NU, et al. Distinct brain networks for adaptive and stable task control in humans. Proc. Natl. Acad. Sci. USA. 2007;104:11073–11078. doi: 10.1073/pnas.0704320104.
- Rubinov M, Sporns O. Complex network measures of brain connectivity: uses and interpretations. Neuroimage. 2010;52:1059–1069. doi: 10.1016/j.neuroimage.2009.10.003.
- Sporns O, Honey CJ, Kotter R. Identification and classification of hubs in brain networks. PLoS ONE. 2007;2:e1049. doi: 10.1371/journal.pone.0001049.
- Ashburner J. A fast diffeomorphic image registration algorithm. Neuroimage. 2007;38:95–113. doi: 10.1016/j.neuroimage.2007.07.007.
Source: PubMed